📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: DuoCort Pharma

1.1 - Company Overview

DuoCort Pharma Logo

DuoCort Pharma

Headquarter: Sweden
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug development focused on improving glucocorticoid therapy; originated among researchers at Sahlgrenska University Hospital in Gothenburg and Uppsala University in Sweden; developer of Plenadren, an improved glucocorticoid replacement therapy.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to DuoCort Pharma

Quellis Bio Logo

Quellis Bio

HQ: United States Website
  • Description: Provider of next-generation antibody therapies aimed at improving outcomes for patients with serious rare diseases, focusing on discovering best-in-class new molecules to address underserved treatment needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quellis Bio company profile →
AesRx Logo

AesRx

HQ: United States Website
  • Description: Provider of biopharmaceutical drug development focused on orphan diseases, developing two novel candidates, Aes-103 and Aes-210. Lead program Aes-103 is a potential breakthrough for treating sickle cell disease, a recessive hemoglobin disorder that can cause red blood cells to deform.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AesRx company profile →
Sobi Logo

Sobi

HQ: Sweden Website
  • Description: Provider of orphan and specialty pharmaceuticals for rare and life-threatening diseases, developing, marketing and distributing treatments across haematology, cardiology, infectious and metabolic disorders, genetic diseases, and conditions in immunocompromised patients; portfolio includes Alprolix, Elocta, Synagis, Kineret, Orfadin, and Gamifant.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sobi company profile →
Wilson Therapeutics Logo

Wilson Therapeutics

HQ: Sweden Website
  • Description: Provider of biopharmaceutical R&D focused on rare diseases, developing Decuprate as a new treatment for Wilson Disease, currently in a Phase II clinical study; based in Stockholm, Sweden.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Wilson Therapeutics company profile →
Censa Pharmaceuticals Logo

Censa Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapeutics for (ultra) orphan CNS disorders, primarily focused on their development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Censa Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for DuoCort Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to DuoCort Pharma

2.2 - Growth funds investing in similar companies to DuoCort Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for DuoCort Pharma

4.2 - Public trading comparable groups for DuoCort Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to DuoCort Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About DuoCort Pharma

What does DuoCort Pharma do?

DuoCort Pharma is a provider of drug development focused on improving glucocorticoid therapy; originated among researchers at Sahlgrenska University Hospital in Gothenburg and Uppsala University in Sweden; developer of Plenadren, an improved glucocorticoid replacement therapy.

Who are DuoCort Pharma's competitors?

DuoCort Pharma's competitors and similar companies include Quellis Bio, AesRx, Sobi, Wilson Therapeutics, and Censa Pharmaceuticals.

Where is DuoCort Pharma headquartered?

DuoCort Pharma is headquartered in Sweden.

How many employees does DuoCort Pharma have?

DuoCort Pharma has 1,000 employees 🔒.

When was DuoCort Pharma founded?

DuoCort Pharma was founded in 2010 🔒.

What sector and industry vertical is DuoCort Pharma in?

DuoCort Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for DuoCort Pharma

Who are the top strategic acquirers in DuoCort Pharma's sector and industry

Top strategic M&A buyers and acquirers in DuoCort Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for DuoCort Pharma?

Top strategic M&A buyers groups and sectors for DuoCort Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in DuoCort Pharma's sector and industry vertical

Which are the top PE firms investing in DuoCort Pharma's sector and industry vertical?

Top PE firms investing in DuoCort Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in DuoCort Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in DuoCort Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in DuoCort Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to DuoCort Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in DuoCort Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for DuoCort Pharma?

The key public trading comparables and valuation benchmarks for DuoCort Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for DuoCort Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for DuoCort Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in DuoCort Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for DuoCort Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in DuoCort Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in DuoCort Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for DuoCort Pharma